ST-elevation myocardial infarction after COVID-19 infection in a young man with Kawasaki disease

Area of Science:

• Cardiology
• Infectious Diseases
• Pediatric Cardiology

Background:

• Kawasaki disease is a critical illness in children that can lead to coronary artery abnormalities.
• Myocardial infarction (MI) in young adults is rare but serious, necessitating investigation into underlying causes.
• Recent viral infections, including COVID-19, have been implicated in cardiovascular complications.

Observation:

• A 22-year-old male with a history of Kawasaki disease presented with an inferior ST elevation myocardial infarction (STEMI).
• The patient had a recent COVID-19 infection approximately one month prior to the STEMI event.
• He had discontinued his prescribed medication 10 days before the onset of myocardial infarction.

Findings:

• The case highlights a potential link between prior Kawasaki disease, recent COVID-19 infection, and the development of STEMI in a young adult.
• Cessation of medication in patients with a history of Kawasaki disease may increase cardiovascular risk.
• This presentation underscores the importance of long-term cardiovascular monitoring in individuals with Kawasaki disease.

Implications:

• Further research is needed to elucidate the mechanisms by which COVID-19 and Kawasaki disease may predispose young individuals to myocardial infarction.
• Clinicians should maintain a high index of suspicion for cardiovascular events in young patients with a history of Kawasaki disease, especially after viral infections.
• Adherence to medical therapy is crucial for managing long-term cardiovascular risks in patients with Kawasaki disease.